• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    US Stocks Mixed; Private Sector Payrolls Increase Less Than Expected

    11/1/23 9:42:28 AM ET
    $CLLS
    $IRIX
    $MNPR
    $PATI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $CLLS alert in real time by email

    U.S. stocks traded mixed this morning, ahead of interest rate decision from the Federal Reserve.

    Following the market opening Wednesday, the Dow traded down 0.05% to 33,036.63 while the NASDAQ rose 0.32% to 12,892.45. The S&P 500 also rose, gaining, 0.15% to 4,199.94.

    Check This Out: $2.8M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying

     

    Leading and Lagging Sectors

     

    Information technology shares jumped by 0.5% on Wednesday.

    In trading on Wednesday, utilities shares fell by 0.3%.

     

    Top Headline

     

    Private businesses in the U.S. added 113,000 workers in October, compared to market estimates of a 150,000 increase and versus a gain of 89,000 in the prior month.

     

    Equities Trading UP

     

    Cellectis S.A. (NASDAQ:CLLS) shares shot up 154% to $2.45. Cellectis reported strategic collaboration and investment agreements with AstraZeneca. Cellectis also presented pre-clinical data on multi-armored allogeneic MUC1-CAR T-cells targeting triple-negative breast cancer at the Society for Immunotherapy of Cancer 38th Annual Meeting.

    Shares of Patriot Transportation Holding, Inc. (NASDAQ:PATI) got a boost, shooting 105% to $15.75. Patriot Transportation announced an agreement under which United Petroleum Transports will acquire all of the outstanding shares of Patriot common stock for $16.26 per share in cash.

    Monopar Therapeutics Inc. (NASDAQ:MNPR) shares were also up, gaining 42% to $0.6383. Monopar presented data showing tumor reduction benefit of camsirubicin from ongoing Phase 1b in patients with advanced soft tissue sarcoma at the 2023 Connective Tissue Oncology Society Annual Meeting.

     

    Equities Trading DOWN

     

    WeWork Inc. (NYSE:WE) shares dropped 50% to $1.1317 following reports that the company is nearing bankruptcy.

    Shares of IRIDEX Corporation (NASDAQ:IRIX) were down 45% to $1.82. Iridex has withdrawn its previously announced annual guidance for 2023 and plans to provide additional information during its third-quarter earnings release based on the information available at that time.

    Paycom Software, Inc. (NYSE:PAYC) was down, falling 37% to $154.05. Paycom Software reported worse-than-expected third-quarter sales results and issued FY23 revenue guidance below estimates.

    Also Check This Out: Top 3 Consumer Stocks That Could Sink Your Portfolio In Q4

     

    Commodities

     

    In commodity news, oil traded up 2.8% to $83.27 while gold traded up 0.1% at $1,996.10.

    Silver traded down 0.3% to $22.885 on Wednesday while copper rose 0.5% to $3.6665.

     

    Euro zone

     

    European shares were higher today. The eurozone’s STOXX 600 gained 0.5%, London’s FTSE 100 rose 0.4% while Spain’s IBEX 35 Index rose 0.4% The German DAX gained 0.4% French CAC 40 climbed 0.4%, while Italy’s FTSE MIB Index jumped 0.5%.

    The S&P Global/CIPS UK manufacturing PMI was revised lower to 44.8 in October from the preliminary reading of 45.2, while Nationwide House Price Index fell by 3.3% year-over-year in October.

     

    Asia Pacific Markets

     

    Asian markets closed mixed on Wednesday, with Japan’s Nikkei 225 rising 2.41%, Hong Kong’s Hang Seng Index falling 0.06% and China’s Shanghai Composite Index gaining 0.14%. India’s S&P BSE Sensex, meanwhile, slipped around 0.4%.

    Retail sales in Hong Kong surged 10.1% year-over-year in September versus a 11% increase in the prior month. The S&P Global India manufacturing PMI fell to 55.5 in October from 57.5, while the Caixin China general manufacturing PMI declined to 49.5 in October from 50.6 in the previous month. The au Jibun Bank Japan manufacturing PMI was revised higher to 48.7 in October.

     

    Economics

     

    Private businesses in the U.S. added 113,000 workers in October, compared to market estimates of a 150,000 increase and versus a gain of 89,000 in the prior month.

    Now Read This: These 3 Real Estate Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts

    Get the next $CLLS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CLLS
    $IRIX
    $MNPR
    $PATI

    CompanyDatePrice TargetRatingAnalyst
    Cellectis S.A.
    $CLLS
    2/17/2026$7.00Buy
    Jefferies
    Paycom Software Inc.
    $PAYC
    2/12/2026$175.00 → $137.00Market Perform
    BMO Capital Markets
    Monopar Therapeutics Inc.
    $MNPR
    1/9/2026$115.00Overweight
    Morgan Stanley
    Paycom Software Inc.
    $PAYC
    12/17/2025$195.00Buy
    BTIG Research
    Monopar Therapeutics Inc.
    $MNPR
    11/14/2025Strong Buy → Outperform
    Raymond James
    Monopar Therapeutics Inc.
    $MNPR
    11/10/2025$115.00Outperform
    Leerink Partners
    Monopar Therapeutics Inc.
    $MNPR
    10/13/2025$125.00Overweight
    Barclays
    Paycom Software Inc.
    $PAYC
    9/26/2025$270.00Buy
    Guggenheim
    More analyst ratings

    $CLLS
    $IRIX
    $MNPR
    $PATI
    SEC Filings

    View All

    Paycom Software Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Paycom Software, Inc. (0001590955) (Filer)

    4/23/26 4:10:16 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Monopar Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Monopar Therapeutics (0001645469) (Filer)

    4/20/26 6:22:12 AM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Cellectis S.A.

    6-K - Cellectis S.A. (0001627281) (Filer)

    4/13/26 4:35:06 PM ET
    $CLLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CLLS
    $IRIX
    $MNPR
    $PATI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Paycom named top retail workforce management solution provider for second consecutive year

    Paycom Software, Inc. (NYSE:PAYC) ("Paycom"), a leading provider of comprehensive, cloud-based human capital management software, was named Overall Workforce Management Solution Provider of the Year by RetailTech Breakthrough Awards for the second consecutive year. The awards recognize innovative technology companies in the retail industry, which currently accounts for about 15.4 million domestic jobs, according to the U.S. Bureau of Labor Statistics. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260423733673/en/Paycom named Overall Workforce Management Solution Provider of the Year by RetailTech Breakthrough Awards for the sec

    4/23/26 9:15:00 AM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Paycom Software, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call

    Paycom Software, Inc. ("Paycom") (NYSE:PAYC), a leading provider of comprehensive, cloud-based human capital management software, will release its results for the first quarter ended Mar. 31, 2026, after the market closes on May 6. Paycom will also hold a conference call to discuss results at 5 p.m. (Eastern) that day. Dial-in #: +1 (833) 461-5787 Access Code: 317740632 The conference call will also be webcast at investors.paycom.com. An archived version will be available at the website following the call. About Paycom Paycom Software, Inc. (NYSE:PAYC) is a cloud-based human capital management software provider that allows organizations of all sizes across

    4/21/26 4:05:00 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026

    WILMETTE, Ill., April 19, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. ("Monopar" or the "Company") (NASDAQ:MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, announced new analyses from the randomized controlled Phase 3 FoCus trial of ALXN1840 (tiomolibdate choline, TMC) showing greater neurologic benefit versus standard of care (SoC) in Wilson disease patients with neurologic symptoms at baseline. The data will be presented today at the American Academy of Neurology (AAN) Annual Meeting 2026, taking place April 18-22, 2026. In a late-breaker oral and poster presentation titled "Greater clinical benefit with t

    4/19/26 7:00:00 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CLLS
    $IRIX
    $MNPR
    $PATI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Novel Inspiration International Co., Ltd.

    4 - IRIDEX CORP (0001006045) (Issuer)

    4/3/26 1:55:32 PM ET
    $IRIX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 4 filed by Robinson Chandler

    4 - Monopar Therapeutics (0001645469) (Issuer)

    4/2/26 3:03:36 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Cittadine Andrew

    4 - Monopar Therapeutics (0001645469) (Issuer)

    4/2/26 3:03:03 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CLLS
    $IRIX
    $MNPR
    $PATI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Dizon Romeo R bought $1,399 worth of shares (1,110 units at $1.26), increasing direct ownership by 0.93% to 121,000 units (SEC Form 4)

    4 - IRIDEX CORP (0001006045) (Issuer)

    3/9/26 1:05:37 PM ET
    $IRIX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Chief Financial Officer Dizon Romeo R bought $2,942 worth of shares (2,200 units at $1.34), increasing direct ownership by 2% to 119,890 units (SEC Form 4)

    4 - IRIDEX CORP (0001006045) (Issuer)

    2/17/26 12:55:35 PM ET
    $IRIX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Chief Financial Officer Dizon Romeo R bought $2,145 worth of shares (1,500 units at $1.43), increasing direct ownership by 1% to 117,690 units (SEC Form 4)

    4 - IRIDEX CORP (0001006045) (Issuer)

    2/12/26 10:05:32 AM ET
    $IRIX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $CLLS
    $IRIX
    $MNPR
    $PATI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies resumed coverage on Cellectis with a new price target

    Jefferies resumed coverage of Cellectis with a rating of Buy and set a new price target of $7.00

    2/17/26 7:48:16 AM ET
    $CLLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BMO Capital Markets reiterated coverage on Paycom Software with a new price target

    BMO Capital Markets reiterated coverage of Paycom Software with a rating of Market Perform and set a new price target of $137.00 from $175.00 previously

    2/12/26 6:46:23 AM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Morgan Stanley initiated coverage on Monopar Therapeutics with a new price target

    Morgan Stanley initiated coverage of Monopar Therapeutics with a rating of Overweight and set a new price target of $115.00

    1/9/26 9:05:54 AM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CLLS
    $IRIX
    $MNPR
    $PATI
    Financials

    Live finance-specific insights

    View All

    Paycom Software, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call

    Paycom Software, Inc. ("Paycom") (NYSE:PAYC), a leading provider of comprehensive, cloud-based human capital management software, will release its results for the first quarter ended Mar. 31, 2026, after the market closes on May 6. Paycom will also hold a conference call to discuss results at 5 p.m. (Eastern) that day. Dial-in #: +1 (833) 461-5787 Access Code: 317740632 The conference call will also be webcast at investors.paycom.com. An archived version will be available at the website following the call. About Paycom Paycom Software, Inc. (NYSE:PAYC) is a cloud-based human capital management software provider that allows organizations of all sizes across

    4/21/26 4:05:00 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

    MOUNTAIN VIEW, Calif., March 26, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ:IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results for the fourth quarter and full year ended January 3, 2026. Fourth Quarter 2025 Financial Highlights Generated total revenue of $14.7 million, representing growth of 16% year-over-year compared to $12.7 million in the prior year quarterCyclo G6® product family revenue was $3.8 million, representing growth of 15% year-over-year compared to $3.3 million in the prior year quarter Sold 15,900 Cycl

    3/26/26 4:05:00 PM ET
    $IRIX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Cellectis to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

    NEW YORK, March 12, 2026 (GLOBE NEWSWIRE) -- Cellectis (the "Company") ((Euronext Growth: ALCLS, NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it will report financial results for the fourth quarter and full year 2025 ending December 31, 2025 on Thursday, March 19, 2026 after the close of the US market. The publication will be followed by an investor conference call and webcast on Friday, March 20, 2026, at 8:00 AM ET / 1:00 PM CET. The call will include the Company's fourth quarter and full year 2025 results and an update on business activities. Details for the call are

    3/12/26 4:30:00 PM ET
    $CLLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CLLS
    $IRIX
    $MNPR
    $PATI
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at Monopar Therapeutics Inc. on Jun 21 Indicate?

    Monopar Therapeutics Inc. has recently seen notable insider activity, with Chief Operating Officer Cittadine Andrew purchasing $25,574 worth of shares on June 21st, 2024. This purchase, comprising 32,508 units at $0.79, increased Cittadine's direct ownership by 21% to 186,132 units as reported in the SEC Form 4. When analyzing this transaction alongside other recent insider activities within the company, interesting patterns and trends start to emerge. Looking back, Cittadine Andrew has been consistently adding to his position in Monopar Therapeutics Inc. over the past few months, showcasing a strong conviction in the company's future prospects. On May 31st, Cittadine Andrew made a substan

    6/22/24 8:00:00 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CLLS
    $IRIX
    $MNPR
    $PATI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Monopar Therapeutics Inc.

    SC 13D/A - Monopar Therapeutics (0001645469) (Subject)

    12/17/24 5:01:42 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Paycom Software Inc.

    SC 13D/A - Paycom Software, Inc. (0001590955) (Subject)

    12/13/24 7:06:11 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Paycom Software Inc.

    SC 13G - Paycom Software, Inc. (0001590955) (Subject)

    11/14/24 4:07:41 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    $CLLS
    $IRIX
    $MNPR
    $PATI
    Leadership Updates

    Live Leadership Updates

    View All

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer

    WILMETTE, Ill., March 02, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (NASDAQ:MNPR) ("Monopar" or the "Company"), a clinical‐stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced the appointment of Susan Rodriguez as Chief Commercial and Strategy Officer, effective immediately. In this newly created executive role, Ms. Rodriguez will lead the Company's commercial strategy and infrastructure build-out as Monopar prepares for the planned submission of a New Drug Application ("NDA") to the U.S. Food and Drug Administration ("FDA") in the first half of 2026 for ALXN1840, its late-stage investigational therapy for Wilson d

    3/2/26 8:00:00 AM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Paycom promotes Shane Hadlock to lead IT; appoints Rachael Gannon to chief automation officer

    Brad Smith named senior technical strategist Paycom Software, Inc. (NYSE:PAYC) ("Paycom"), a leading provider of comprehensive, cloud-based human capital management software, today announced the expanded role of Shane Hadlock as Paycom's chief client officer and chief technology officer and the promotion of Rachael Gannon to chief automation officer, effective Aug. 18. Brad Smith has been named the company's senior technical strategist and will continue reporting to CEO Chad Richison. As chief technology officer, Hadlock will oversee Paycom's IT department, while maintaining his chief client officer role and leadership of Paycom's client service groups. "Shane's exceptional client-cen

    8/18/25 4:05:00 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology